San Carlos, Calif. -- Nektar Therapeutics, a San Carlos-based developer
of drug delivery technologies, said on Monday that it will acquire
Mountain View-based Aerogen, a maker of nebulizer products that treat
respiratory disorders, for $32 million in cash and stock. The deal consists
of about $8 million and cash and $24 million in stock. Nektar said that the
deal will add inhaleable liquid drug technology to its portfolio of
inhaleable powdered drug technologies.
http://biz.yahoo.com/bw/050815/155358.html?.v=1